Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01431378Terminated

Pilot Study of Model Based Iterative Reconstruction Using 64-Slice

Role: collaborator

NCT00963651Completed

GE Healthcare VolumeRAD Lung Nodule Detection Study

Role: lead

NCT00882609Phase 3Unknown

F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets

Role: lead

All 3 trials loaded